THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Hudson Bay Capital Management LP's Holding History (CIK: 0001393825)

Note: Option positions (PUT/CALL) are excluded.

Q2 2021

Shares 240,437 Value ($000) $3,491 Avg Close $18.78 Range $14.46 - $22.74

Q1 2021

Shares 170,000 Value ($000) $3,470 Avg Close $19.01 Range $16.46 - $21.21

Q4 2020

Shares 275,000 Value ($000) $4,887 Avg Close $17.95 Range $14.48 - $20.53

Q3 2020

Shares 320,000 Value ($000) $4,731 Avg Close $18.73 Range $14.62 - $22.82

Q2 2020

Shares 180,000 Value ($000) $3,778 Avg Close $25.69 Range $20.17 - $31.35

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2021	240,437	$3,491	$18.78	$14.46 - $22.74
Q1 2021	170,000	$3,470	$19.01	$16.46 - $21.21
Q4 2020	275,000	$4,887	$17.95	$14.48 - $20.53
Q3 2020	320,000	$4,731	$18.73	$14.62 - $22.82
Q2 2020	180,000	$3,778	$25.69	$20.17 - $31.35